These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4835097)

  • 1. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma.
    McCoy JL; Jerome LF; Dean JH; Cannon GB; Alford TC; Doering T; Herberman RB
    J Natl Cancer Inst; 1974 Jul; 53(1):11-7. PubMed ID: 4835097
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human leukocyte migration in agarose by KC1 extracts of lung cancer.
    Boddie AW; Holmes EC; Roth JA
    Surg Forum; 1974; 25(0):109-10. PubMed ID: 4439134
    [No Abstract]   [Full Text] [Related]  

  • 3. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
    J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors.
    Kronman BS; Shapiro HM; Localio SA
    Dis Colon Rectum; 1972; 15(2):106-10. PubMed ID: 5026786
    [No Abstract]   [Full Text] [Related]  

  • 6. Responses of neoplasms to local immunotherapy.
    Klein E; Holtermann OA; Case RW; Milgrom H; Rosner D; Adler S
    Am J Clin Pathol; 1974 Aug; 62(2):281-9. PubMed ID: 4602090
    [No Abstract]   [Full Text] [Related]  

  • 7. The delayed hypersensitivity reaction in breast cancer.
    Roberts MM; Jones-Williams W
    Br J Surg; 1974 Jul; 61(7):549-52. PubMed ID: 4846148
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic responses in cancer patients.
    Solowey AC; Rapaport FT
    Surg Gynecol Obstet; 1965 Oct; 121(4):756-60. PubMed ID: 5838283
    [No Abstract]   [Full Text] [Related]  

  • 9. IMMUNOLOGIC RESPONSE OF PATIENTS WITH PSORIASIS.
    LANDAU J; GROSS BG; NEWCOMER VD; WRIGHT ET
    Arch Dermatol; 1965 Jun; 91():607-10. PubMed ID: 14295522
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Prognostic indications in cancer.
    Turnbull AR; Connolly CE; Jones BM
    Br Med J; 1975 Jun; 2(5971):612-3. PubMed ID: 1131636
    [No Abstract]   [Full Text] [Related]  

  • 11. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon.
    Stewart TH
    Cancer; 1969 Jun; 23(6):1368-79. PubMed ID: 4181583
    [No Abstract]   [Full Text] [Related]  

  • 12. The delayed hypersensitivity response in primary breast carcinoma as an index of host resistance.
    Mitchell RJ
    Br J Surg; 1972 Jul; 59(7):505-8. PubMed ID: 5041100
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
    Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
    Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer.
    McCoy JL; Jerome LF; Cannon GB; Weese JL; Herberman RB
    J Natl Cancer Inst; 1977 Nov; 59(5):1413-8. PubMed ID: 909101
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of glucocorticosteroids on antigen-induced leukocyte migration inhibition.
    Andrianakos AA; Tsichlis PN; Merikas EG; Efstratopoulos AD; Sharp JT; Marketos SG; Merikas GE
    Mater Med Pol; 1979; 11(1):10-4. PubMed ID: 480973
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnostic and prognostic significance of delayed hypersensitivity skin testing in patients with urological cancer.
    Williams G; Castro JE
    Br J Urol; 1975 Feb; 47(1):97-101. PubMed ID: 1131501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation in vivo, with delayed hypersensitivity skin tests, of cell mediated immunity in patients with severe obesity].
    Adami GF; Griffanti Bartoli F; Traverso E; Scopinaro N
    Minerva Med; 1980 Jun; 71(25):1769-72. PubMed ID: 7413106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the delayed cutaneous hypersensitivity response in hepatoma patients: test by antigen of streptokinase and streptodornase.
    Lee CS; Hwang KL; Tsai CH; Lin TY
    Taiwan Yi Xue Hui Za Zhi; 1978 Aug; 77(8):616-20. PubMed ID: 214514
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.